Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential Chemotherapy for Locally Advanced TNBC
NCT01969032Phase 2Completed
- Sponsor
- Russian Academy of Sciences
- Start
- Aug 2011
- Primary completion
- May 2014
- Modality
- DNA Intercalators/Alkylators, Targeted Liposomes, Irreversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection, carboplatin, pegylated liposomal doxorubicin, cyclophosphamide, capecitabine in triple-negative breast cancer (TNBC), sponsored by Russian Academy of Sciences. Started Aug 2011; status: completed.
02
Drugs
Paclitaxel Micelles for Injectioncarboplatinpegylated liposomal doxorubicincyclophosphamidecapecitabine
03
Conditions
triple-negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT01969032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01969032.